<p>In this podcast, Dr Michael Reid from&nbsp;University of California, San Francisco, discusses the prevalence of obesity in patients with HIV, HIV treatments that may lead to obesity, and other...
<p>Dr Michael Bloch from Blue Spruce Medical Consultants talks about the ACP's new hypertension guidance, the new "prehypertension" group of patients,&nbsp;and more.</p>
Andrew Meltzer, MD, from the George Washington University School of Medicine and Health Sciences, discusses his latest research, which suggests that the guideline-recommended medication tamsulosin may not...
<p>In this podcast, Dr Eva Yuan from UT Southwestern Medical Center/Children's Medical Center Dallas discusses the unusual case from the June 2018 Photo Quiz.</p>
Joel Gelfand, MD, MSCE, from the University of Pennsylvania's Perelman School of Medicine, discusses his research on the interaction between psoriasis medication and cardiovascular disease.
Jamie Koufman, MD, from the Voice Institute of New York discusses proton pump inhibitors—their&nbsp;adverse effects, alternatives, and more.</p>
Daniel Einhorn, MD, from Scripps Whittier Diabetes Institute talks about the "debate of 2018": ACP's new guidance on controlling HbA1c levels in adults with diabetes.
Dr Seth Baum interviews Dr Mikhail Kosiborod about clinical trial data surrounding the possible mechanisms of action of SLGT2 inhibitors for heart failure, as well as the cardio-renal connection.
In this podcast, Dr Laura Hollar from Washington University School of Medicine discusses her latest Diabetes Q&A column about the interaction between diabetes and vitamin D deficiency.
Dr Peter Jones from Houston Methodist Hospital discusses cardiovascular disease and lipids, topics in which he is speaking about during Consultant360's Cardiometabolic Risk Summit this year.
